Aims and Scope

For many years, the journal has been the main source of scientific information for those working in clinical diagnostic laboratories and has played a central role in the advancement of clinical laboratory services in Russia.

The journal aims to be the foremost resource for Russia’s laboratory community on the following topics and issues:

  • the most promising directions for research in all fields of laboratory medicine,
  • evidence-based means of laboratory analysis and methods for clinical laboratory diagnosis,
  • enhancing the work of public health laboratories and improving the practice of laboratory medicine (developing a well-trained public health laboratory workforce and providing it with refresher courses and legal advice; refining and formalizing laboratories’ core functions and interactions; improving logistics and procurement practices; elucidating other economic aspects of clinical laboratory activities),
  • new legislative acts or good practice guidance issued by the regulatory bodies that govern the establishment and operations of laboratories, as well as consensus standards and guidelines developed by professional organizations, and
  • professional and public lives of laboratory scientists.

The journal features empirical and theoretical contributions by an international community of scholars from scientific, educational, and medical institutions. It publishes original articles, literature reviews, lectures of eminent experts in different fields of laboratory medicine, clinical analyses of diagnostically difficult cases, academic and technical discussions and exchanges among scholars and healthcare providers, and information on meetings and conferences. The journal also publishes Russian translations of foreign articles from top-class authors (particularly those published in the Clinical Chemistry Journal, which is in accordance with the agreement made between Clinical Laboratory Diagnostics and this journal).

 

Sections

Статьи

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Peer Review Process

Peer-Review Policy

All articles submitted to the editorial office of a journal shall be reviewed in the manner set forth below.
1. The editorial staff shall establish whether the submission is within the scope of the journal and meets the format criteria. The editorial staff shall then forward it either to the Editor-in-Chief, to the Deputy Editor-in-Chief or to the Executive Editor, who shall decide whether the research results described in the article are valid and important. If the results are deemed valid and important, reviewers shall be determined. All articles shall be reviewed by the Editorial Board and the Editorial Council, as well as by independent reviewers. Independent reviewers must be leading experts in the field and have some publications (not older than three years) on the subject covered in the submitted article. Articles submitted by the Editor-in-Chief shall be reviewed by independent reviewers.
2. The review process is confidential. The editorial staff shall send the author/s copies of the reviews or a rejection letter. The editorial staff shall also send copies of the reviews to the Ministry of Education and Science of the Russian Federation, upon a request from the Ministry.
3. The review process requires 2 months. The editorial staff controls the length of the review process; in some circumstances (upon a reviewer’s request), more time may be given to complete the review.
4. To help produce a comprehensive and unbiased review of an article, Editorial Team has developed Instructions for Reviewers that contain a list of criteria to be assessed. Based on the assessment of the criteria, reviewers shall be asked to determine the status of the article in one of the following ways: (a) accept, (b) accept with revision as suggested by the reviewer, (c) re-review required, or (d) reject.
5. A review suggesting corrections and revisions to the submitted article shall be forwarded by the editorial staff to the author, who will be requested either to prepare a revised version of the article based on the recommendations made by the reviewer or to prove that such corrections and/or revisions are not needed. A revised article shall be sent to the reviewers to be re-reviewed.
6. In cases of irreconcilable differences between the author and reviewer, the Editorial Board reserves the right to send the article to another reviewer. Should a conflict arise, the article shall be sent to a member of the Editorial Board or Editorial Council. The final decision shall rest with the Editor-in-Chief.
7. Authors may be requested to list names of potential reviewers when submitting a publication.
8. Submitted articles may be sent to an expert in medical statistics for an additional review.
9. The author shall be notified of a negative review by email.
10. A positive review does not obligate the journal to publish the submitted article. The final decision shall be made by the Editorial Board based on whether the article presents valid data and is in scope for the journal.
11. Authors may appeal a rejection of their article by the editors. Appeal procedures are described at:
12. Originals of the reviews shall be stored at the editorial office for 5 years.

 

Publication Frequency

Frequency: 12 issues per year

 

Open Access Policy

The publications in the Journal are available to all interested from the moment of publication. So, this journal provides immediate Gold Open Access (in accordance with Budapest Open Access Initiative) to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. Also the editorial board belives that it provides free public access to the results of research and contributes to the advancement of science and medicine.

Free Full-text access to all articles can be observed via several websites (www.journals.eco-vector.com/0869-2084, www.elibrary.ru). All accepted articles publish with the Creative Commons International license (CC BY) for more freely distribution and usage worlwide.

 

Editorial Board

Editor-in-Chief
Andrey Yu. Mironov — MD, PhD, Prof., Head of the Department of Microbiology, G.N. Gabrichevsky Research Institute for Epidemiology and Microbiology of Rospotrebnadzor (Moscow, Russia)

Executive Secretary
Galina G. Kharseeva — M.D., Professor, Head of the Microbiology and Virology Department No. 2 at the Rostov State Medical University, Russian Federation Ministry of Public Health. A supervisor of one successfully defended doctoral and five candidate’s theses. A certified bacteriologist, regional office head of the Russian Biotechnology Society.

Anatoly B. Dobrovolsky — PhD, Prof., Leading Researcher, Laboratory of Clinical Problems of Atherothrombosis, Russian Cardiology Research and Production Complex of the Russian Ministry of Health (Moscow, Russia)

Vladimir V. Dolgov — MD, PhD, Prof., Head of the Department of Clinical Laboratory Diagnostics, Russian Medical Academy of Postgraduate Education (Moscow, Russia)

Galina N. Zubrikhina — MD, PhD, Leading Researcher, Clinical Diagnostic Laboratory, Centralized Clinical Laboratory Department, N.N. Blokhin Russian Cancer Research Center (Moscow, Russia)

Alexey A. Ivanov — MD, PhD, Prof., Deputy Director, Institute of Molecular Medicine, I.M. Sechenov First Moscow State Medical University (Moscow Russia)

Svetlana A. Lugovskaya — MD, PhD, Prof., Department of Clinical Laboratory Diagnostics, Russian Medical Academy of Postgraduate Education (Moscow, Russia)

Seifaddin G. Mardanly — Doctor of Medical Sciences,
Professor at the Department of Pharmacology and Pharmaceutical Sciences, State University of Humanities and Technology, R&D Director CJSC EKOlab.

Victoria T. Morozova — MD, PhD, Prof., Department of Clinical Laboratory Diagnostics, Russian Medical Academy of Postgraduate Education, Honored Worker of Science of Russia (Moscow, Russia)

Lyudmila M. Skuin — MD, PhD, Associate Prof., Department of Immunology, Russian Medical Academy of Postgraduate Education (Moscow, Russia)

Areg A. Totolyan — MD, PhD, Prof., Corresponding Member of the Russian Academy of Sciences, Deputy Director, Pasteur St. Petersburg Scientific Research Institute of Epidemiology and Microbiology of Rospotrebnadzor (Saint Petersburg)

Irina P. Shabalova — MD, PhD, Prof., Department of Clinical Laboratory Diagnostics, Russian Medical Academy of Postgraduate Education (Moscow, Russia)

Editorial Council:

Vladimir V. Alabovsky — MD, PhD, Prof., Head of the Department of Biochemistry, Voronezh State Medical University named after N.N. Burdenko (Voronezh, Russia)

Tatyana V. Vavilova — MD, PhD, Associate Prof., Head of the Department of Clinical Laboratory Diagnostics, V.A. Almazov Federal Medical Research Center of the Ministry of Health of the Russian Federation (Saint Petersburg, Russia)

Alexander Z. Gilmanov — MD, PhD, Prof., Head of the Department of Clinical Laboratory Diagnostics, Institute of Postgraduate Education, Bashkir State Medical University of the Ministry of Health of the Russian Federation (Ufa, Russia)

John A. Grishchenko — Head of the Clinical Diagnostic Laboratory, Federal Center of Cardiovascular Surgery of the Ministry of Health of the Russian Federation (Krasnoyarsk, Russia)

Natalia G. Dashkova — MD, PhD, Senior Researcher, Head of the Clinical Diagnostic Laboratory of Blood Center, I.M. Sechenov First Moscow State Medical University (Moscow, Russia)

Tatiana I. Dolgih — MD, PhD, Prof., Head of the Clinical Diagnostic Laboratory, Omsk Region Clinical Diagnostic Center (Omsk, Russia)

Svetlana A. Elchaninova — MD, PhD, Prof., Head of the Department of Biochemistry and Clinical Laboratory Diagnostics, Altai State Medical University (Barnaul, Russia)

Anton V. Indutny — MD, PhD, Associate Prof., Head of the Department of Clinical Laboratory Diagnostics, Head of the Scientific and Educational Center of Laboratory Medicine, Omsk State Medical University (Omsk, Russia)

Anatoly I. Karpishchenko — MD, PhD, Prof., Head of the Section of Clinical Laboratory Diagnostics, Medical Information and Analytical Center (Saint Petersburg, Russia)

Kirill P. Kashkin — MD, PhD, Prof., Academician of the Russian Academy of Sciences, Head of the Department of Immunology, Russian Medical Academy of Postgraduate Education (Moscow, Russia)

Gennady I. Koziniec — MD, PhD, Prof., Honored Worker of Science (Moscow, Russia)

Anton V. Kozlov — MD, PhD, Prof., Head of the Department of Clinical Laboratory Diagnostics, North-Western State Medical University named after I.I. Mechnikov (Saint Petersburg, Russia)

Anatoliy G. Kochetov — MD, PhD, Prof., Department of Higher Level General Medicine with the Course on Clinical Laboratory Diagnostics, Peoples’ Friendship University of Russia, Head of the Department of Experimental and Theoretical Investigations of the Mechanisms of Behavior and Brain Protection, Research Institute of Cerebrovascular Disease and Stroke, Pirogov Russian National Research Medical University; Chief (Visiting) Specialist on Clinical Laboratory Diagnostics of the Russian Ministry of Health (Moscow, Russia)

Nikolai E. Kushlinsky — MD, PhD, Prof., Corresponding Member of the Russian Academy of Sciences, Head of the Laboratory of Clinical Biochemistry, N.N. Blokhin Russian Cancer Research Center; Head of the Department of Clinical Biochemistry and Laboratory Diagnostics, Moscow State University of Medicine and Dentistry named after A.I. Evdokimov (Moscow, Russia)

Ayrat R. Mavzyutov — MD, PhD, Prof., Head of the Department of Fundamental and Applied Microbiology, Prof., Department of Clinical Laboratory Diagnostics, Institute of Postgraduate Education, Bashkir State Medical University (Ufa, Russia)

Vladimir N. Malakhov — MD, PhD, Prof., Head of the Non-Commercial Partnership «Center for External Control Assessment of the Quality of Clinical Laboratory Studies» (Moscow, Russia)

Dmitry D. Menshikov — MD, PhD, Prof., Chief Researcher, Clinical Microbiology Laboratory, N.V. Sklifosovsky Research Institute of Emergency Medicine of the Department of Health of Moscow

Evgeniy N. Ovanesov — Head of TECHNOMEDICA Research and Production Enterprise (Moscow, Russia)

Yuri V. Pervuschin — MD, PhD, Prof., Head of the Department of Clinical Laboratory Diagnostics, Head of the Course on Bacteriology, Institute of Postgraduate and Additional Education, Stavropol State Medical University (Stavropol, Russia)

Ilya V. Pikalov — MD, PhD, Prof., Head of the Department of Clinical Laboratory Diagnostics, Novosibirsk State Medical University (Novosibirsk, Russia)

Yuri P. Reznikov — MD, PhD, Prof., Scientific Director of the Polyclinic №1 of the Presidential Administration of the Russian Federation (Moscow, Russia)

Dmitry B. Saprygin — MD, PhD, Prof., Department of Biochemistry, Russian Medical Academy of Postgraduate Education of the Ministry of Health of the Russian Federation, Consultant of the Medical Center of Administration for Service to the Diplomatic Corps (Moscow, Russia)

Sergei N. Suplotov — MD, PhD, Prof., Head of the Department of Clinical Laboratory Diagnostics, Tyumen State Medical Academy (Tyumen, Russia)

Olga A. Tarasenko — MD, PhD, Prof., Deputy Chief Physician, Head Center for Hygiene and Epidemiology of the Federal Medical and Biological Agency (Moscow, Russia)

Igor S. Tartakovsky — PhD, Prof., Head of the Laboratory of Legionellosis, N.F. Gamaleya Scientific Research Institute of Epidemiology and Microbiology (Moscow, Russia)

Lina A. Khorovskaya — MD, PhD, Prof., Department of Clinical Laboratory Diagnostics, Pavlov First St. Petersburg State Medical University (Saint Petersburg, Russia)

Sergei V. Tsvirenko — MD, PhD, Prof., Head of the Department of Clinical Laboratory Diagnostics and Bacteriology, Ural State Medical University (Yekaterinburg, Russia)

Alexander N. Shibanov — PhD, CEO of OOO «Unimed Management» (Moscow, Russia)

Vladimir L. Emanuel — MD, PhD, Prof., Head of the Department of Clinical Laboratory Diagnostics, Head of the Course on Molecular Medicine, Head of the Scientific and Educational Complex «Institute of Laboratory Medicine», Pavlov First St. Petersburg State Medical University (Saint Petersburg, Russia)

Galina A. Yarovaya — PhD, Prof., Head of the Department of Biochemistry, Russian Medical Academy of Postgraduate Education of the Ministry of Health of the Russian Federation (Moscow, Russia)

Foreign Editorial Council Members:

Kallner Anders — MD, PhD, Department of Laboratory Diagnostics of Karolinska Hospital (Stockholm, Sweden)

Syrjanen Kari — MD, PhD, FIAG, Medical Director of the Department of Clinical Research Biohit Oyj; Editor-in-Chief of «Acta Cytologica» (Helsinki, Finland)

Ian D. Watson — MD, PhD, Clinical Director of Clinical Laboratories at Liverpool Aintree University Hospital (Liverpool, UK)

Abdumalik N. Aripov — MD, PhD, Prof., Head of the Department of Clinical Laboratory Diagnostics, Tashkent Institute of Postgraduate Medical Education, Head of the Biochemical Laboratory, Republican Specialized Scientific and Practical Medical Center (Tashkent, Uzbekistan)

Valentin S. Gudumak — MD, PhD, Prof., Department of Clinical Laboratory Diagnostics, Faculty of Postgraduate Professional Training of Physicians, Head of the Biochemical Laboratory, Nicolae Testemițanu State University of Medicine and Pharmacy; Chairman of the Committee on Laboratory Medicine of the Ministry of Health of Moldova (Chisinau, Moldova)

Valery A. Deev — MD, PhD, Prof., A.A. Shalimov National Institute of Surgery and Transplantology of the National Academy of Medical Sciences of Ukraine (Kiev, Ukraine)

Vladimir G. Kolb — MD, PhD, Prof. (Minsk, Belarus)

Georgiy M. Kostin — MD, PhD, Associate Prof., Head of the Clinical Diagnostic Laboratory, Minsk Consulting and Diagnostic Center (Minsk, Belarus)

Ganna G. Luneva — MD, PhD, Prof., Head of the Department of Clinical Laboratory Diagnostics, National Medical Academy for Postgraduate Education named after P.L. Shupyk, Chairman of the Ukrainian Association of Clinical Laboratory Diagnostics (Kiev, Ukraine)

Vasiliy I. Nigulyanu — MD, PhD, Prof., Head of the Department of Clinical Laboratory Diagnostics, Faculty of Postgraduate Professional Training of Physicians, of the Chisinau Medical Institute (Chisinau, Moldova)

 

Indexation

The journal is indexed in the following international reference and information services:

  • Chemical Abstracts

  • Scopus

  • PubMed

  • EBSCO

  • Russian Science Citation Index (Web of Science)

 

 

Publication ethics Statement

Responsibilities of the Editorial Board

The Editorial Board of the journal complies with the ethical standards approved by the international scientific community. The Editorial Board uses the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals of the International Committee of Medical Journal Editors and recommendations of the Committee on Publication Ethics (COPE).

Editorial decision-making

The Editorial Board is responsible for making decisions which of the submitted manuscripts will be accepted for publication. The Editorial Board makes the decision regarding a publication based on the journal’s policy, taking into account the current authors’ rights legislation and avoiding defamation and plagiarism. The editorial evaluation of the manuscript is independent of race, ethnicity and gender, religion, citizenship, or political views of the authors. Decision whether to publish an article or not is based exclusively on its scientific relevance, originality, clarity of presentation, and correspondence of the topic to journal’s specialization.

Confidentiality

All the Editorial Board members are responsible for disclosing any information about the submitted manuscript to individuals other than authors, peer reviewers, potential peer reviewers, or publishers.

Conflict of interest

The unpublished materials disclosed in the submitted manuscript cannot be used by the Editorial Board members for their own research without written permission from the authors.

Plagiarism, data falsification, and error correction

In case of an ethical complaint or a conflict situation regarding the manuscript or the published article, the Editorial Board should undertake reasonable countermeasures, together with the publisher, to restore the violated rights. If errors are revealed, the Editorial Board should assist in publishing corrections or refutations. Each reported case of unethical behavior will be considered, even if submitted several years after the article had been published.

Reviewer responsibilities

Contribution to editorial decision-making

The review process is aimed at facilitating the Editorial Board in editorial decision-making and may also help the author to improve the manuscript.

Timeliness (promptness)

If a reviewer selected by the Editorial Board does not feel competent for reviewing the manuscript or feels that it is not possible to meet the deadline of the review, he/she should promptly notify the Editorial Board and decline to perform the review.

Confidentiality

Any material under review should be regarded as confidential. The material should not be shared or discussed with anyone outside the review process unless approved by the editor.

Objectivity standards

Reviewing should be objective. Subjective critique of the author is not allowed. Reviewer’s opinion should be stated clearly and supported by arguments.

Confirmation of the resources

The reviewer is responsible for determining the cases when the relevant publications have not been cited in the manuscript or listed in the References section. Furthermore, the reviewer should determine whether all the statements, conclusions, and ideas borrowed from other publications had the corresponding references. If the reviewer detects that the manuscript under review significantly coincides with or is similar to another known publication, he/she should notify the Editorial Board.

Disclosure of information and conflict of interest

Non-disclosable information and ideas must be regarded as confidential and cannot be used for one’s personal advantage. Experts should not review manuscripts if they have any possible conflict of interest due to competitive, collaborative, or other relationships with the manuscript authors, as well as companies or institutions related to the manuscript.

Author responsibilities

Credibility and study standards

If the manuscript is based on an original study, the authors must submit the reliable results of their work and an objective discussion of significance of the study. The manuscript should contain all the key data, accurate description of the study details and references in order to ensure reproducibility of the results. Data falsification or the intentionally invalid statements in the manuscript are regarded as unethical and are inappropriate.

Data availability

The Editorial Board can request the authors to submit raw data in addition to the manuscript. The author must be ready to provide public access to these data, provided that public access to the data violates neither confidentiality of the research participants nor rights of an individual or a company owning these data.

Originality, plagiarism, and citing the sources

Authors must submit only original studies. Authors must properly and accurately acknowledge the work of others. Publications that had significantly contributed to preparing the study or underlied its design should also be acknowledged.

Multiple, duplicate, or competing publications

In general, materials describing the contents of the same study should not be published in more than one journal. Submitting the manuscript to more than one journal is considered unethical and inappropriate. Copyrighted materials that have already been published cannot be submitted to the journal. Furthermore, materials under consideration by the Editorial Board must not be submitted to be published elsewhere. When submitting an article, the author must inform the editor about all the previous presentations of the study that can be regarded as a duplicate publication. The author must notify the editor if the manuscript contains the information published by the author in previous reports or submitted for publication elsewhere. In this case, the new article should contain references to the previously published material.

Authorship criteria

Authorship is limited to the individuals that have made a significant contribution to 1) conception and design of the study; data acquisition and interpretation; 2) preparing the first draft of the article or editing the article to improve its quality; and 3) final approval of the manuscript for publication. Each author must participate in the study to an extent sufficient to take public responsibility for the corresponding part of the content of his/her article. Involvement consisting in funding or selecting material for the article is not sufficient reason for inclusion in the list of authors. General guidance of the research group is not sufficient for including in the list of authors.

All the authors must approve the final manuscript and its submission to the journal for publication.

Conflict of interest

When submitting an article to the journal, all authors must sign the form disclosing financial or any other substantive conflict of interest that can be considered to have influenced the study results or their interpretation. All funding sources of the submitted studies must be specified.

Involvement in the peer review process

After the peer review process, the article can be sent to the author for improvement. Authors should be actively involved in the review process: promptly answer the questions and, if necessary, correct the manuscript in accordance with the reviewer’s comments.

 

Appeal procedure

Authors have a right to appeal editorial decisions to adopt or reject articles.

1. In case of disagreement with the editorial decision of acceptance or rejection of the article, the author refers to the relevant journal editors in writing indicating the reasons for treatment

2. Committee on Conflict Resolution of the respective journal considers the appeal

3. Change in editorial decisions regarding an article possible in cases where: – Author gave more actual results, which are not taken into account during the primary reviewing of the article – Author provided with information about conflict of interest that was not provided in the primary reviewing of this article – Author expresses his concern about biased reviews

4. If there are sufficient grounds the Committee on Conflict Resolution of the relevant journal makes a proposal for editorial board to change or to uphold the initial decision regarding the publication of the article

5. If necessary, editors may involve additional reviewer for final decision

6. Editorial board of the journal makes a decision regarding acceptance or rejection on the basis of reviewing of the initial decision

7. Editorial decision following its review of the initial decision is final and is not subject to appeal.

 

Article Retraction

Retraction of a published article is a measure of the last resort and may occur under circumstances such as:

– infringements of law and defamation;

– more than 20% of direct quotes or paraphrased material;

– false or inaccurate data that, if acted upon, would pose a serious health risk;

– a vague and incomplete description of conflicts of interests.

Article Retraction Procedure

1. Retraction of an article shall be initiated upon a written request by authors, readers, reviewers, editors, or publishers that shall be submitted to the journal in which the article was published.

2. The journal’s Commission on Conflict Resolution shall examine the request.

3. The Commission on Conflict Resolution shall decide to retract the article if there is sufficient evidence to do so.

4. Upon consideration of the request, the Commission on Conflict Resolution shall notify the person who initiated article removal of its decision.

5. Should the Commission decide to retract the article, this shall be agreed on with the authors, and the journal shall publish a retraction statement that shall include the article’s metadata.

6. If the journal’s articles are indexed in databases, the journal shall notify the databases that the article has been retracted and should not be cited, identifying the reasons for the retraction.

 

Appeal procedure

Authors have a right to appeal editorial decisions to adopt or reject articles.

1. In case of disagreement with the editorial decision of acceptance or rejection of the article, the author refers to the relevant journal editors in writing indicating the reasons for treatment

2. Committee on Conflict Resolution of the respective journal considers the appeal

3. Change in editorial decisions regarding an article possible in cases where: – Author gave more actual results, which are not taken into account during the primary reviewing of the article – Author provided with information about conflict of interest that was not provided in the primary reviewing of this article – Author expresses his concern about biased reviews

4. If there are sufficient grounds the Committee on Conflict Resolution of the relevant journal makes a proposal for editorial board to change or to uphold the initial decision regarding the publication of the article

5. If necessary, editors may involve additional reviewer for final decision

6. Editorial board of the journal makes a decision regarding acceptance or rejection on the basis of reviewing of the initial decision

7. Editorial decision following its review of the initial decision is final and is not subject to appeal

 

Article Retraction

Retraction of a published article is a measure of the last resort and may occur under circumstances such as:

– infringements of law and defamation;

– more than 20% of direct quotes or paraphrased material;

– false or inaccurate data that, if acted upon, would pose a serious health risk;

– a vague and incomplete description of conflicts of interests.

Article Retraction Procedure

1. Retraction of an article shall be initiated upon a written request by authors, readers, reviewers, editors, or publishers that shall be submitted to the journal in which the article was published.

2. The journal’s Commission on Conflict Resolution shall examine the request.

3. The Commission on Conflict Resolution shall decide to retract the article if there is sufficient evidence to do so.

4. Upon consideration of the request, the Commission on Conflict Resolution shall notify the person who initiated article removal of its decision.

5. Should the Commission decide to retract the article, this shall be agreed on with the authors, and the journal shall publish a retraction statement that shall include the article’s metadata.

6. If the journal’s articles are indexed in databases, the journal shall notify the databases that the article has been retracted and should not be cited, identifying the reasons for the retraction.

 

Preprint and postprint Policy

Prior to acceptance and publication in our journals, authors may make their submissions available as preprints on personal or public websites.

As part of submission process, authors are required to confirm that the submission has not been previously published, nor has been submitted. After a manuscript has been published in our journal we suggest that the link to the article on journal’s website is used when the article is shared on personal or public websites.

Glossary (by SHERPA)

Preprint – In the context of Open Access, a preprint is a draft of an academic article or other publication before it has been submitted for peer-review or other quality assurance procedure as part of the publication process. Preprints cover initial and successive drafts of articles, working papers or draft conference papers.
 
Postprint – The final version of an academic article or other publication – after it has been peer-reviewed and revised into its final form by the author. As a general term this covers both the author’s final version and the version as published, with formatting and copy-editing changes in place.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies